KROS

Keros Therapeutics (KROS)

About Keros Therapeutics (KROS)

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.

Details

Daily high

$12.11

Daily low

$11.38

Price at open

$11.60

52 Week High

$22.55

52 Week Low

$10.42

Market cap

238.8M

Dividend yield

0.00%

Volume

394,559

Avg. volume

292,351

P/E ratio

6.63

Keros Therapeutics News